Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1
2006
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Cochrane Database of Systematic Reviews
2003 Standout
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
2002
Candida and the paediatric lung
2009
Clinical Epidemiology of Stenotrophomonas maltophilia Colonization and Infection
2002
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Fluoroquinolone Antibiotics in Infants and Children
2005
Successful treatment of Stenotrophomonas maltophilia meningitis in a preterm baby boy: a case report
2009
Nocardiosis: Updated Clinical Review and Experience at a Tertiary Center
2010 Standout
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
2007
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Candida albicanspathogenicity mechanisms
2013 Standout
Management of meningitis due to antibiotic-resistant Acinetobacter species
2009
Cytokine Gene Polymorphisms and the Outcome of Invasive Candidiasis: A Prospective Cohort Study
2011
Epidemiological Investigation of Fluoroquinolone Resistance in Infections Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coliandKlebsiella pneumoniae
2001
Glucocorticoids and invasive fungal infections
2003
Fluoroquinolones in the treatment of meningitis
2003
Treatment of bacterial meningitis
2002
Echinocandin antifungal drugs
2003 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Infections due to emerging and uncommon medically important fungal pathogens
2004
Successful treatment of multi-resistant Stenotrophomonas maltophilia meningitis with ciprofloxacin in a pre-term infant
2002
Helicobacter pylori and Extragastric Diseases – Other Helicobacters
2005
GRADE guidelines 6. Rating the quality of evidence—imprecision
2011 Standout
Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
2006
Mycoses in Pediatric Patients
2006
Immunity to fungal infections
2011 Standout
Candida lusitaniaeInfections in the Era of Fluconazole Availability
2003
Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes
2011
-D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
2004
Emerging and less common fungal pathogens
2002
Rapid Identification of Clinically Relevant Nocardia Species to Genus Level by 16S rRNA Gene PCR
1999
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Candida Infections of Medical Devices
2004 Standout
Antifungal Susceptibility ofCandidaBiofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins
2002
Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action
2017 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Nocardiosis
2003 Standout
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
2012
Anticytokine Autoantibody–Associated Immunodeficiency
2014
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Invasive Candidiasis
2015 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
2005
Rapid identification of clinically relevant Nocardia species using real-time PCR with SYBR Green and melting-curve analysis
2006
Clinical and Laboratory Features of theNocardiaspp. Based on Current Molecular Taxonomy
2006 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Comparison of Biofilms Formed byCandidaalbicansandCandidaparapsilosison Bioprosthetic Surfaces
2002
Works of F Mateička being referenced
Incidence of Autoantibodies Against Type I and Type II Interferons in a Cohort of Systemic Lupus Erythematosus Patients in Slovakia
2003
Identification of Borrelia burgdorferi sensu lato Tick Isolates from Slovakia by PCR Typing with 16S rRNA Primers
1997
Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol
1999
Prospective study on fungemia in children with cancer: analysis of 35 cases and comparison with 130 fungemias in adults
2000
Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review
1999
Persistent Fungemia - Risk Factors and Outcome in 40 Episodes
2001
Nosocomial candidaemias due to species other than Candida albicans in cancer patients
1999
Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes
1998
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study
1998
NosocomialCandida kruseiFungemia in Cancer Patients: Report of 10 Cases and Review
1999
[Seroprevalence of Helicobacter pylori in rheumatoid arthritis and its relationship to pharmacotherapy].
2004
Invasive infections due toClavispora lusitaniae
1999
Bacteremia Due to CiprofLoxacin-Resistant Pseudomonas Aeruginosain Cancer Patients: Risk Factors for Resistance and Outcome of 25 Episodes. A Case-Control Study
1999